ABSTRACT
This chapter is the first of two about the methods that are used to estimate risks of adverse events following immunisation (AEFI), using epidemiological data obtained in field studies (as distinct from the pre-licensure studies of vaccines undertaken in randomised controlled clinical trials). This chapter focuses on methodological issues specific to epidemiological studies of vaccine safety.
